Compare SYRE & IPAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SYRE | IPAR |
|---|---|---|
| Founded | 2013 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.6B |
| IPO Year | 2016 | 1988 |
| Metric | SYRE | IPAR |
|---|---|---|
| Price | $34.16 | $102.03 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 6 |
| Target Price | $56.50 | ★ $125.50 |
| AVG Volume (30 Days) | ★ 569.5K | 209.0K |
| Earning Date | 02-26-2026 | 02-24-2026 |
| Dividend Yield | N/A | ★ 3.17% |
| EPS Growth | N/A | ★ 9.68 |
| EPS | N/A | ★ 5.13 |
| Revenue | N/A | ★ $1,463,838,000.00 |
| Revenue This Year | N/A | $3.49 |
| Revenue Next Year | N/A | $1.93 |
| P/E Ratio | ★ N/A | $19.70 |
| Revenue Growth | N/A | ★ 3.12 |
| 52 Week Low | $10.91 | $77.21 |
| 52 Week High | $35.31 | $148.15 |
| Indicator | SYRE | IPAR |
|---|---|---|
| Relative Strength Index (RSI) | 57.61 | 74.71 |
| Support Level | $30.92 | $96.68 |
| Resistance Level | $34.07 | $102.06 |
| Average True Range (ATR) | 1.80 | 2.68 |
| MACD | -0.03 | 0.42 |
| Stochastic Oscillator | 78.41 | 96.93 |
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
Interparfums Inc operates in the fragrance business and produces and distributes a wide array of prestige fragrance and fragrance-related products. It sells its product under the brand which includes Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lacoste, Lanvin, Moncler, Montblanc, Rochas and Van Cleef & Arpels. The company operates in two operating segments namely European based operations, SA, and United States based operations.. The group sells its products to department stores, perfumeries, specialty stores, and domestic and international wholesalers and distributors.